Amneal Pharmaceuticals is rolling out its generic of Trisenox (arsenic trioxide injection. The drug, which had already been approved by the Food and Drug Administration, is indicated to treat acute ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Arsenic Trioxide Injection in a 10 mg per 10 mL vial presentation. The product is ...
SEATTLE, June 15, 2017 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ and MTA:CTIC) today announced that it has received a $10 million milestone payment from Teva Pharmaceutical Industries Ltd. related ...
A pharmacokinetic (PK) dose escalation study of DX-8951f (DX) in adult cancer patients with hepatic dysfunction: A comparison of the NCI hepatic dysfunction criteria and the Child-Pugh classification ...
CTI BioPharma Corp. (NASDAQ and MTA: CTIC) today announced that it has received a $10 million milestone payment from Teva Pharmaceutical Industries Ltd. (Teva) related to the achievement of sales ...
Cell Therapeutics said the U.S. Food and Drug Administration approved the supplemental new drug application allowing the manufacturing, labeling and testing of Trisenox, used for the treatment of ...
Single agent liposomal-encapsulated (Lipo) all-trans retinoic acid (ATRA) can cure patients with untreated acute promyelocytic leukemia (APL): An update and comparison with an ATRA+idarubicin ...
Well known as a poison that can kill, arsenic also can prolong the lives of patients with a rare form of leukaemia, a new study out on Saturday found. "This study shows that even more patients will ...
Cell Therapeutics Inc., with its drug Trisenox (arsenic trioxide) already approved for acute promyelocytic leukemia and more oncology products in the pipeline, filed to offer $150 million in ...
* Teva receives fda priority review for first line use of trisenox® (arsenic trioxide) in patients with low to intermediate risk acute promyelocytic leukemia (apl) Sign up here. * Teva Pharmaceutical ...
CHICAGO (Reuters) - Arsenic, the poison of choice for many a murder mystery, can significantly extend survival in patients with a rare form of leukemia, U.S. researchers said on Saturday. Sign up here ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results